Mammary tumors induced by polyomavirus

Breast Cancer Research and Treatment

Volumn 39, Issue 1, 1996, Pages 45-56

  Fluck, Michele M ^a   Haslam, Sandra Z ^b  

^a Michigan State University ^*  (United States)

^b MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Middle T antigen; Neonatal mice; Nude mice; Oncogenesis; Polyomavirus induced mammary tumor model; Transgenic mice

Indexed keywords

VIRUS MIDDLE T ANTIGEN; VIRUS PROTEIN;

ANIMAL MODEL; ARTICLE; BREAST ADENOCARCINOMA; BREAST CARCINOGENESIS; BREAST TUMOR; CANCER MODEL; IMMUNE DEFICIENCY; MOUSE; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; TRANSGENIC MOUSE; VIRUS CARCINOGENESIS; VIRUS CELL TRANSFORMATION;

ANIMALS; ANIMALS, NEWBORN; CARCINOMA, DUCTAL, BREAST; CELL TRANSFORMATION, NEOPLASTIC; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, NUDE; MICE, TRANSGENIC; POLYOMAVIRUS; POLYOMAVIRUS INFECTIONS; TUMOR VIRUS INFECTIONS; VIRUS REPLICATION;

EID: 0029997249     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01806077     Document Type: Article

References (49)

1. Brady JN, Salzman NP: The papovaviruses: General properties of polyomavirus and SV40. In: Salzman NP (ed) The Papovaviridae. Plenum Press, New York, 1986, p 1
2. Eckhart W: Polyomavirinae and their replication. In: Fields BN, Knipe DM, et al (eds) Fundamental Virology. Raven Press Ltd, New York, 1991, p 727
3. Salzman NP, Natarajan V, Selzer GB: Transcription of SV40 and polyomavirus and its regulation. In: Salzman NP (ed) The Papovaviridae. Plenum Press, New York, 1986, p 27
4. Tooze J: DNA Tumor Viruses: Molecular Biology of Tumor Viruses (2nd ed). Cold Spring Harbor Laboratory, New York, 1981
5. Courtneidge SA, Smith AE: Polyoma virus transforming protein associates with the product of the c-src cellular gene. Nature (London) 303:435-439, 1983
6. Kornbluth S, Sudol M, Hanafusa H: Association of the polyomavirus middle-T antigen with c-yes protein. Nature (London) 325:171-173, 1987
7. fyn with middle tumor antigen in murine polyomavirus-transformed rat cells. J Virol 63:2343-2347, 1989
8. Schaffhausen BS, Benjamin TL: Phosphorylation of polyoma T antigens. Cell 18:935-946, 1979
9. Hunter T, Hutchinson MA, Eckhart W: Polyoma middle-sized T antigen can be phosphorylated on tyrosine at multiple sites in vitro. EMBO J 3:73-79, 1984
10. Whitman M, Kaplan DR, Schaffhausen BS, Cantley L, Roberts TM: Association of phosphatidylinositol kinase activity with polyoma middle-T competent for transformation. Nature (London) 315:239-242, 1985
11. Kaplan DR, Whitman M, Schaffhausen BS, Raptis L, Garcea RL, Pallas D, Roberts TM, Cantley L: Phosphatidylinositol metabolism and polyoma-mediated transformation. Proc Natl Acad Sci USA 83: 3624-3628, 1986
12. Dilworth SM, Brewster CEP, Jones MD, Lanfrancome L, Pelici G, Pelici PG: Transformation by polyoma virus middle T-antigen involves the binding and tyrosine phosphorylation of Shc. Nature (London) 367:87-90, 1994
13. Campbell KS, Ogris E, Burke B, Su W, Auger KR, Druker BJ, Schaffhausen BS, Roberts TM, Pallas DC: Polyoma middle tumor antigen interacts with SHC protein via the NPTY (Asn-Pro-Thr-Tyr) motif in middle tumor antigen. Proc Natl Acad Sci USA 91:6344-6348, 1994
14. c-src. J Virol 64:105-112, 1990
15. Marcellus R, Whitfield JF, Raptis L: Polyoma virus middle tumor antigen stimulates membrane-associated protein kinase C at lower levels than required for phosphatidylinositol kinase activation and neoplastic transformation. Oncogene 6:1037-1040, 1991
16. Wasylyk C, Imler JL, Wasylyk B: Transforming but not immortalizing oncogenes activate the transcription factor PEA1. EMBO J 7:2475-2483, 1988
17. Wasylyk C, Flores P, Gutman A, Wasylyk B: PEA3 is a nuclear target for transcription activation by non-nuclear oncogenes. EMBO J 8:3371-3378, 1989
18. Gutman A, Wasylyk B: The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites. EMBO J 9:2241-2246, 1990
19. Tang WJ, Berger SL, Trieszenberg SJ, Folk WR: Nucleotides in the polyomavirus enhancer that control viral transcription and DNA replication. Mol Cell Biol 7:1681-1690, 1987
20. Chen MC, Redenius D, Ozati-Ashtiani F, Fluck MM: Enhancer-mediated role for polyomavirus middle T / small T in DNA replication. J Virol 69:326-333, 1994
21. Garcea RL, Ballmer-Hofer K, Benjamin TL: Virion assembly defect of polyomavirus hr-t mutants: Underphosphorylation of major capsid protein VP1 before viral DNA encapsidation. J Virol 54:311-316, 1985
22. Grussenmeyer T, Scheidtmann KH, Hutchinson MA, Eckhart W, Walter G: Complexes of polyoma virus medium T antigen and cellular proteins. Proc Natl Acad Sci USA 82:7952-7954, 1985
23. van der Burg B, de Groot RP, Isbrucker L, Kruijer W, de Laat SW: Direct stimulation by estrogen of growth factor signal transduction pathways in human breast cancer cells. J Steroid Biochem Mol Biol 43:111-115, 1992
24. Guy CT, Muthuswamy SK, Cardiff RD, Soriano P, Muller WJ: Activation of the c-Src tyrosine kinase is required for the induction of mammary tumors in transgenic mice. Genes Devel 8:23-32, 1994
25. Guy CT, Cardiff RD, Muller WJ: Induction of mammary tumors by expression of polyomavirus middle T oncogene: A transgenic mouse model for metastatic disease. Mol Cell Biol 12:954-961, 1992
26. Muller WJ, Sinn E, Pattengale EK, Wallace R, Leder P: Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell 54:105-115, 1988
27. DePamphilis ML, Bradley MK: Replication of SV40 and polyoma virus chromosomes. In: Salzman NP (ed) The Papovaviridae. Plenum Press, New York, 1986, p 99
28. Pipas JM: Common and unique features of T antigens encoded by the polyomavirus group. J Virol 66:3979-3985, 1992
29. Dyson N, Bernards R, Friend SH, Gooding LR, Hassell JA, Major EO, Pipas JM, Vandyke T, Harlow E: Large T antigens of many polyomaviruses are able to form complexes with the retinoblastoma protein. J Virol 68:668-673, 1990
30. Larose A, Dyson N, Sullivan M, Harlow E, Bastin M: Polyomavirus large T antigen mutants affected in retinoblastoma binding are defective in immortalization. J Virol 65:2308-2313, 1991
31. Fluck MM: Tumor studies with polyomaviruses. In: Bertino JR (ed) Molecular Biology of Cancer. Academic Press, San Diego, in press
32. Gross L: The polyoma virus. In: Gross L (ed) Oncogenic Viruses (3d ed). Pergamon Press, Oxford, 1983, vol 2, p 737
33. Dawe CJ, Freund R, Mandel G, Ballmer-Hofer K, Talmage DA, Benjamin TL: Variations in polyoma virus genotype in relation to tumor induction in mice. Am J Pathol 127:243-261, 1987
34. Dubensky TW, Villareal LP: The primary site of replication alters the eventual site of persistent infection by polyomavirus in mice. J Virol 50:541-546, 1984
35. Wirth JJ, Amalfitano A, Gross R, Oldstone MBA, Fluck MM: Organ- and age-specific replication of polyomavirus in mice. J Virol 66:3278-3286, 1992
36. Allison AC: Immune responses to polyoma virus and polyoma virus-induced tumors. In: Klein F (ed) Viral Oncology. Raven Press, New York, 1980, p 481
37. Wirth JJ, Fluck MM: Immunological elimination of infected cells as the candidate mechanism for tumor protection in polyomavirus-infected mice. J Virol 65:6985-6988, 1991
38. Freund R, Dawe CJ, Carroll JP, Benjamin TL: Changes in frequency, morphology, and behavior of tumors induced in mice by a polyoma virus mutant with a specifically altered oncogene. Am J Pathol 141:1409-1425, 1992
39. Freund R, Bronson RT, Benjamin TL: Separation of immortalization from tumor induction with polyoma large T mutants that fail to bind the retinoblastoma gene product. Oncogene 7:1979-1987, 1992
40. Berebbi M, Dandolo L, Hassoun J, Bernard AM, Blangy D: Specific tissue targeting of polyoma virus oncogenicity in athymic nude mice. Oncogene 2:149-156, 1988
41. Haslam SZ, Wirth JJ, Counterman LJ, Fluck MM: Characterization of the mammary hyperplasia, dysplasia, and neoplasia induced in athymic female adult mice by polyomavirus. Oncogene 7:1295-1303, 1992
42. Rondinelli-Heindel R, Haslam SZ, Fluck MM: The role of ovarian hormones, age and mammary gland development in polyomavirus mammary tumorigenesis. Oncogene, in press
43. Sharkey SM, Bruce WR: Quantitation of nuclear aberrations as a screen for agents damaging to mammary epithelium. Carcinogenesis 7:1991-1995, 1986
44. Haslam SZ: The ontogeny of mouse mammary gland responsiveness to ovarian steroids. Endocrinol 125: 2766-2772, 1989
45. Haslam SZ, Counterman LJ, Nummy KA: The effects of EGF, estrogen and progestin on DNA synthesis in vivo are determined by the developmental state of the mammary gland. J Cell Physiol 155:72-79, 1993
46. Haslam SZ: Acquisition of estrogen-dependent progesterone receptors by normal mouse mammary gland. J Steroid Biochem 31:9-13, 1988
47. Wang S, Counterman LJ, Haslam SZ: Progesterone action in normal mouse mammary gland. Endocrinol 127:2183-2189, 1990
48. DiFronzo G, Coradini D, Cappelletti V, et al: Hormone receptors and disease free survival in breast cancer: impact of increasing threshold levels. Anticancer Res 10:1699-1705, 1990
49. Swanson GM, Lin CS: Survival patterns among younger women with breast cancer: the effects of age, race, stage, and treatment. Monogr Natl Cancer Inst 16:69-77, 1994